Although the sports-specific adaptations and differentiation of an athlete'
s heart (AH) were first described 100 years ago, the condition is still an
area of active debate. In clinical practice, there is often an obvious lack
of basic knowledge concerning the prerequisites and well established exten
t of the structural and functional characteristics of an AH. Some misunders
tandings arise from the somewhat misleading term 'athlete's heart' because
not every athlete, even if he or she is training and competing at a very hi
gh level, develops an enlarged heart. Such a condition can only be expected
after years of quantitative and qualitative demanding aerobic endurance tr
aining.
Although the correlation with competitive performance of endurance events i
s rather low in trained athletes, the relationship between heart dimensions
and ergometric performance represents an important criterion for different
iation between physiological and pathological cardiac enlargement. The asse
ssment of measures exceeding the usual clinical limits, especially concerni
ng volume-dependent echocardiographic parameters, also requires considerati
on of the strong influence of anthropometric data.
The existence of a concentric left ventricular hypertrophy (LVH) in strengt
h-rained athletes is still a topic of debate in the literature, but is reje
cted by most recent well-conducted trials. In our review, only bodybuilders
using anabolic steroids exhibited a distinctly higher hypertrophic index c
ompared with all other groups of endurance or strength athletes.
Current unsolved issues in clinical sports medicine concern the early detec
tion of myocardial complications in athletes exercising during infectious d
iseases, and the eligibility for competitive sport in cases of borderline L
VH.